PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Core for Cell Technology, School of Medicine, Pontifícia Universidade Católica Do Paraná, 1155 Imaculada Conceição Street, Prado Velho, Curitiba, PR, 80215-901, Brazil. carmen.rebelatto@pucpr.br.\', \'Complexo Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, PR, Brazil. carmen.rebelatto@pucpr.br.\', \'National Institute of Science and Technology for Regenerative Medicine, INCT-REGENERA, Rio de Janeiro, Brazil. carmen.rebelatto@pucpr.br.\', \'Core for Cell Technology, School of Medicine, Pontifícia Universidade Católica Do Paraná, 1155 Imaculada Conceição Street, Prado Velho, Curitiba, PR, 80215-901, Brazil.\', \'Complexo Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, PR, Brazil.\', \'National Institute of Science and Technology for Regenerative Medicine, INCT-REGENERA, Rio de Janeiro, Brazil.\', \'Laboratory of Basic Biology of Stem Cells, Carlos Chagas Institute, Fiocruz-Paraná, Curitiba, PR, Brazil.\', \'Statistics, Health Sciences Sector, Federal University of Paraná, Curitiba, PR, Brazil.\', \'Hospital e Maternidade Brígida, Curitiba, PR, Brazil.\', \'Hospital Nossa Senhora do Pilar, Curitiba, PR, Brazil.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13287-022-02796-1
?:hasPublicationType
?:journal
  • Stem cell research & therapy
is ?:pmid of
?:pmid
?:pmid
  • 35313959
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all